Stemcells, Inc. Reports Second Quarter 2012 Financial Results and Provides ...
MarketWatch (press release)
In July 2012, the California Institute for Regenerative Medicine (CIRM) approved an award to us and our collaborators for up to a $20 million under CIRM's Disease Team Therapy Development Award program (RFA 10-05). The award is to fund preclinical ...


Read Full Article...